M. Colombo

An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection

Atish Mukherji, Frank Jühling, Yogy Simanjuntak, Émilie Crouchet et autres

Chronic liver disease and cancer are global health challenges. The role of the circadian clock as a regulator of liver physiology and disease is well established in rodents, however, the identity and epigenetic regulation of rhythmically expressed genes in human disease is …

fr, jp, us, gb, au, tw, de, it, cn (code pays fourni par la source)

OS-061 Chronic hepatitis C virus infection induces HCC risk by perturbing the human liver circadian transcriptome and epigenome through deregulation of the deacetylase SIRT1

Atish Mukherji, Frank Jühling, Yogy Simanjuntak, Michio Imamura et autres

Dataset related to article "Intrahepatic Cholangiocellular Carcinoma With Radiological Enhancement Patterns Mimicking Hepatocellular Carcinoma"

Luca Viganò, Ana Lleò, Riccardo Muglia, Nicolò Gennaro et autres

This record contains raw data related to article “Intrahepatic Cholangiocellular Carcinoma With Radiological Enhancement Patterns Mimicking Hepatocellular Carcinoma" Abstract Non-invasive diagnosis of hepatocellular carcinoma (HCC) in cirrhotic patients requires demonstration of wash-in and wash-out on contrast-enhanced imaging. Recent studies have reported misclassification …

it (code pays fourni par la source)

Dataset related to article "Intrahepatic Cholangiocellular Carcinoma With Radiological Enhancement Patterns Mimicking Hepatocellular Carcinoma"

Luca Viganò, Ana Lleò, Riccardo Muglia, Nicolò Gennaro et autres

This record contains raw data related to article “Intrahepatic Cholangiocellular Carcinoma With Radiological Enhancement Patterns Mimicking Hepatocellular Carcinoma" Abstract Non-invasive diagnosis of hepatocellular carcinoma (HCC) in cirrhotic patients requires demonstration of wash-in and wash-out on contrast-enhanced imaging. Recent studies have reported misclassification …

it (code pays fourni par la source)

T02.01.15 GASTRIC PERORAL ENDOSCOPIC PYLOROMYOTOMY FOR REFRACTORY GASTROPARESIS: A SYSTEMATIC REVIEW OF EARLY OUTCOMES WITH POOLED ANALYSIS

Marco Spadaccini, Roberta Maselli, Viveksandeep Thoguluva Chandrasekar, Andrea A. Anderloni et autres

Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma

Luca Viganò, Ana Lleò, Riccardo Muglia, Nicolò Gennaro et autres

it (code pays fourni par la source)

Intrahepatic cholangiocellular carcinoma with radiologic enhancement pattern mimicking hepatocellular carcinoma

Luca Viganò, Ana Lleò, Riccardo Muglia, Nicolò Gennaro et autres

it (code pays fourni par la source)

The medical impact of hepatitis D virus infection in Uzbekistan

Malika Erkinovna Khodjaeva, Nargiz Sapievna Ibadullaeva, Aziza Saydullaevna Khikmatullaeva, Elizaveta Joldasova et autres

BACKGROUND & AIMS: The hepatitis B virus (HBV) is endemic in Uzbekistan but the medical impact of infection with the HBV-dependent hepatitis D virus (HDV) is unknown in the Country. An Hepatology Center was recently established at the Institute of Virology in …

uz, sk, it, by (code pays fourni par la source)

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B

Alessandro Loglio, Massimo Alberto Iavarone, Glenda Grossi, Mauro Viganò et autres

BACKGROUND: Long-term oral nucleos(t)ide analogue (NUC) therapy in hepatitis B virus (HBV)-related compensated cirrhotics prevents clinical decompensation but not hepatocellular carcinoma (HCC) development. AIMS: To define the clinical features and outcomes of HCC in long-term NUC-treated HBV patients. METHODS: All HCCs developing …

it (code pays fourni par la source)

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa, Shukui Qin, Baek‐Yeol Ryoo, Sheng‐Nan Lu et autres

Background: Arginine depletion is a putative target in hepatocellular carcinoma (HCC). HCC often lacks argininosuccinate synthetase, a citrulline to arginine-repleting enzyme. ADI-PEG 20 is a cloned arginine degrading enzyme-arginine deiminase-conjugated with polyethylene glycol. The goal of this study was to evaluate this …

us, cn, kr, tw, it, gb (code pays fourni par la source)

Changes of AFP and PIVKA-II levels during DAA treatment and their predictive value for early diagnosis of HCC in HCV cirrhotic patients with SVR to DAA treatment

Angelo Sangiovanni, Roberta D’Ambrosio, Giovanna LUNGHI, Mariangela Bruccoleri et autres

it (code pays fourni par la source)

Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes

Zobair M. Younossi, Maria A. Stepanova, Tarik Asselah, Graham R. Foster et autres

Background: While the necessity of treatment of hepatitis C virus (HCV)-infected patients with advanced liver disease is widely accepted, the benefit of treating patients without significant liver disease is less well established. Our aim was to assess the effect of treating HCV …

us, fr, gb, ca, es, it, au (code pays fourni par la source)